Shaily Engineering Plastics has reported its financial results for the quarter and year ended March 31, 2026. The company's consolidated Profit After Tax (PAT) for FY26 surged by 83% to Rs 169.9 crore, compared to Rs 93.1 crore in the previous year. Revenue from operations for the fiscal year increased by 26% to Rs 990.7 crore, up from Rs 786.8 crore in FY25.

Key Financial Highlights

The company demonstrated strong operational performance with significant improvements in profitability margins. Consolidated EBITDA for FY26 rose by 61% to Rs 287.7 crore, with the EBITDA margin expanding by 630 basis points to 29.0%. For the fourth quarter of FY26, revenue stood at 2.37b Rupees, a 9% increase year-over-year, while net profit grew by 40% to 402m Rupees versus 286m Rupees in the same period last year. Q4 EBITDA came in at 656m Rupees versus 545m Rupees in Q4 FY25, with the EBITDA margin at 27.71% compared to 25.02% in Q4 FY25.

Segment Performance

Improved traction in the healthcare segment was the key driver for overall growth. Healthcare revenue increased by 139% to Rs 392.8 crore in FY26. In Q4 FY26, healthcare revenue grew by 101% to Rs 112.8 crore. Conversely, the Consumer segment faced weaker market demand in Europe and the USA, with revenue declining by 9% to Rs 511.3 crore in FY26 and 31% to Rs 102.1 crore in Q4 FY26. The Industrial segment revenue grew by 41% to Rs 86.6 crore in FY26.

Board Decisions

The Board of Directors, in its meeting held on May 19, 2026, approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board has recommended a Final Dividend of Rs 3 per equity share of Rs 2 each (150%) for the year ended March 31, 2026, subject to the approval of shareholders in the forthcoming Annual General Meeting. Additionally, the Board passed an enabling resolution to raise funds up to Rs 500 crore in one or more tranches through permissible modes such as private placement, preferential issue, or rights issue.

The Board also approved the appointment of M/s Jain & Hindocha, Chartered Accountants, as the Internal Auditor and M/s YS Thakar & Co, Cost Accountants, as the Cost Auditor for F.Y. 2026-27.

Business Updates

The Healthcare segment successfully launched Shaily Harmony and Shaily Neo pens and received an order worth Rs 423 crore from a domestic pharma company for pen injectors. In the Consumer Electronics & Semiconductor segment, the company commenced commercial supplies and signed an agreement with a Korean firm for semiconductor trays. The Board also approved the appointment of Mr. Chi Hung Kam (Mr. Joe Kam) as the Chief Operating Officer – Healthcare, effective from May 20, 2026.

Shaily Engineering Plastics Limited has approved the grant of 3,000 stock options to eligible employees under its Shaily Employee Stock Option Plan 2019. The Nomination and Remuneration Committee of the Board of Directors approved the grant at its meeting held on May 19, 2026. The scheme is in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The total number of shares covered by these options is 3,000 equity shares, each with a face value of ₹2. The options are granted to eligible employees as determined by the committee. The pricing formula for the options is linked to the market price on the date of vesting, with the total value divided into three equal tranches.

Vesting and Exercise Details

The vesting of the options will occur in three equal installments. One-third of the options granted will vest on the completion of one year from the date of grant, the second tranche will vest after two years, and the final tranche will vest after three years. Once vested, the options can be exercised within a period of four years from the date of vesting.

The company noted that the options are yet to be exercised, and consequently, the diluted earnings per share arising from the issue of equity shares is not applicable at this stage. The grant follows a previous approval by shareholders in August 2019, which authorized the issuance of up to 131,570 employee stock options.

ESOP Adjustments

The company also highlighted a recent sub-division of its equity shares. The face value was reduced from ₹10 to ₹2 per share effective November 23, 2023. In view of this sub-division, the total number of options to be granted under the ESOP 2019, including the current grant of 3,000 options, has been augmented proportionally without affecting the rights or obligations of the grantees.